Article Details
Retrieved on: 2018-05-01 20:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb (NYSE:BMY) and <b>Flatiron</b> <b>Health</b>, a market leader in oncology-specific electronic health record software and the curation of regulatory-grade real-world data for cancer research and real-world evidence (RWE) generation, expanded their ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here